Masae Itamochi

Toyama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Genome-Epidemiological and Seroepidemiological Study of the COVID-19 Cluster in a Nursing Home.

Genome-Epidemiological and Seroepidemiological Study of the COVID-19 Cluster in a Nursing Home.

Journal: Japanese journal of infectious diseases

Published: November 30, 2025

Detection of neutralizing antibody against SARS-CoV-2 in a patient with X-linked agammaglobulinemia receiving immunoglobulin replacement therapy

Detection of neutralizing antibody against SARS-CoV-2 in a patient with X-linked agammaglobulinemia receiving immunoglobulin replacement therapy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 05, 2025

A transient reduction of the varicella-zoster virus-specific immunoglobulin G level after vaccination against severe acute respiratory syndrome coronavirus 2 with an mRNA vaccine in nursing home residents, but not staff.

A transient reduction of the varicella-zoster virus-specific immunoglobulin G level after vaccination against severe acute respiratory syndrome coronavirus 2 with an mRNA vaccine in nursing home residents, but not staff.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: November 18, 2024

Development and clinical evaluation of a MPXV antigen-detecting rapid diagnostic test.

Development and clinical evaluation of a MPXV antigen-detecting rapid diagnostic test.

Journal: Journal of virological methods

Published: August 02, 2024

Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection.

Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: July 17, 2024

COVID-19 mRNA booster vaccination induces robust antibody responses but few adverse events among SARS-CoV-2 naïve nursing home residents.

COVID-19 mRNA booster vaccination induces robust antibody responses but few adverse events among SARS-CoV-2 naïve nursing home residents.

Journal: Scientific reports

Published: April 09, 2024

Impact of COVID-19 and Closed Transmission of SARS-CoV-2 during the First Wave in Toyama Prefecture, Japan, March 30 to May 18, 2020.

Impact of COVID-19 and Closed Transmission of SARS-CoV-2 during the First Wave in Toyama Prefecture, Japan, March 30 to May 18, 2020.

Journal: Japanese journal of infectious diseases

Published: November 01, 2023

Long-Term Detection and Isolation of Severe Fever with Thrombocytopenia Syndrome (SFTS) Virus in Dog Urine.

Long-Term Detection and Isolation of Severe Fever with Thrombocytopenia Syndrome (SFTS) Virus in Dog Urine.

Journal: Viruses

Published: October 24, 2023

Virus evolution and reduced viral viability during treatment of persistent COVID-19 Omicron BA.5 infection in an immunocompromised host.

Virus evolution and reduced viral viability during treatment of persistent COVID-19 Omicron BA.5 infection in an immunocompromised host.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: June 08, 2023

Neutralizing Antibody Levels and Epidemiological Characteristics of Patients with Breakthrough COVID-19 Infection in Toyama, Japan.

Neutralizing Antibody Levels and Epidemiological Characteristics of Patients with Breakthrough COVID-19 Infection in Toyama, Japan.

Journal: Japanese journal of infectious diseases

Published: May 31, 2023

Activation of SARS-CoV-2 by trypsin-like proteases in the clinical specimens of patients with COVID-19.

Activation of SARS-CoV-2 by trypsin-like proteases in the clinical specimens of patients with COVID-19.

Journal: Scientific reports

Published: May 12, 2023

Evaluation of SARS-CoV-2 isolation in cell culture from nasal/nasopharyngeal swabs or saliva specimens of patients with COVID-19.

Evaluation of SARS-CoV-2 isolation in cell culture from nasal/nasopharyngeal swabs or saliva specimens of patients with COVID-19.

Journal: Scientific reports

Published: March 10, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026